EnsoData
EnsoData is a healthcare technology company specializing in AI-powered software solutions for sleep medicine. Their flagship product, EnsoSleep, automates the scoring and management of sleep studies, significantly reducing clinician time and improving diagnostic accuracy. The company offers FDA-cleared software as a medical device (SaMD) including EnsoSleep PPG, which uses pulse oximeter data for sleep apnea diagnosis, and a cloud-based platform for sleep study management and remote physiological monitoring (RPM). EnsoData's technology supports clinicians across the entire patient sleep journey, enabling efficient diagnosis, therapy monitoring, and improved patient outcomes. Their AI solutions are used by over 500 US sleep centers, demonstrating strong market traction and adoption. EnsoData's business model is subscription-based, with transparent pricing per study and a monthly minimum. The company emphasizes diversity, equity, and inclusion in its culture and leverages a large database of over 1 million sleep studies to enhance its AI capabilities.
EnsoData
EnsoData is a healthcare technology company specializing in AI-powered software solutions for sleep medicine. Their flagship product, EnsoSleep, automates the scoring and management of sleep studies, significantly reducing clinician time and improving diagnostic accuracy. The company offers FDA-cleared software as a medical device (SaMD) including EnsoSleep PPG, which uses pulse oximeter data for sleep apnea diagnosis, and a cloud-based platform for sleep study management and remote physiological monitoring (RPM). EnsoData's technology supports clinicians across the entire patient sleep journey, enabling efficient diagnosis, therapy monitoring, and improved patient outcomes. Their AI solutions are used by over 500 US sleep centers, demonstrating strong market traction and adoption. EnsoData's business model is subscription-based, with transparent pricing per study and a monthly minimum. The company emphasizes diversity, equity, and inclusion in its culture and leverages a large database of over 1 million sleep studies to enhance its AI capabilities.
TL;DR
Domain: Healthcare AI for sleep medicine
Flagship product: EnsoSleep (AI scoring for PSGs, HSATs) and EnsoSleep PPG
Regulatory status: Multiple FDA 510(k) clearances
Customers: Used by over 500 US sleep centers; supported >1,300,000 patients
Business model: Subscription-based (per-study pricing with monthly minimum)
$20M Series B announced Jun 25, 2025